Werewolf Therapeutics Is Maintained at Market Outperform by JMP Securities

Dow JonesJan 14 09:23 ET

Werewolf Therapeutics Analyst Ratings

BenzingaJan 14 09:14 ET

BofA Securities Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsJan 14 07:31 ET

JMP Securities Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsJan 14 01:32 ET

JMP Securities Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Cuts Target Price to $4

Moomoo NewsJan 13 15:31 ET

Buy Rating Affirmed for Werewolf Therapeutics Amid Strategic Advancements and Strong Financial Position

TipRanksJan 13 15:17 ET

BofA Securities Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsJan 6 06:31 ET

H.C. Wainwright Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsNov 19, 2024 06:31 ET

Werewolf Therapeutics Analyst Ratings

BenzingaNov 19, 2024 06:28 ET

Leerink Partners Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsNov 12, 2024 03:31 ET

JMP Securities Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsNov 11, 2024 06:31 ET

Buy Rating for Werewolf Therapeutics: Strong Financial Position and Promising Pipeline

TipRanksNov 11, 2024 05:58 ET

H.C. Wainwright Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsNov 8, 2024 07:35 ET

BofA Securities Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsSep 10, 2024 06:31 ET

Analysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL) and Chimerix (CMRX)

TipRanksAug 20, 2024 04:32 ET

Leerink Partners Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Announces Target Price $13

Moomoo NewsAug 20, 2024 04:32 ET

Wedbush Adjusts Price Target on Werewolf Therapeutics to $8 From $9, Maintains Outperform Rating

MT NewswiresAug 12, 2024 05:44 ET

Buy Rating Affirmed for Werewolf Therapeutics on Strong Candidate Progress and Promising Safety Profiles

TipRanksAug 9, 2024 07:59 ET

Buy Rating Affirmed: Werewolf Therapeutics' Promising Pipeline and Financial Health

TipRanksAug 9, 2024 01:17 ET

Werewolf Therapeutics Analyst Ratings

BenzingaJul 2, 2024 06:34 ET